ライフサイエンスコーパス: chimeric monoclonal antibody

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 humoral immune responses to the administered chimeric monoclonal antibody.

2 ntigens to two major subsets of DCs by using chimeric monoclonal antibodies.

3 Rituximab, a chimeric monoclonal antibody against CD20, is active in

4 ssed the safety and efficacy of siltuximab-a chimeric monoclonal antibody against interleukin 6-in HI

5 We incorporated cetuximab, a chimeric monoclonal antibody against the epidermal growt

6 ese cells has been recently achieved using a chimeric monoclonal antibody against the pan B cell surf

7 rexate therapy with placebo or infliximab, a chimeric monoclonal antibody against TNF-alpha, in intra

8 Treatment of RA patients with a chimeric monoclonal antibody against tumor necrosis fact

9 in clinical trials include an immunotoxin, a chimeric monoclonal antibody, and an antibody drug conju

10 A phosphorylation site was introduced into chimeric monoclonal antibody B72.3 (MAb-chB72.3) by site

11 to tumor necrosis factor alpha, specifically chimeric monoclonal antibody cA2, in the treatment of Cr

12 The chimeric monoclonal antibody cAC10, directed against CD3

13 Rituximab is a chimeric monoclonal antibody directed against CD20 and u

14 Basiliximab, a chimeric monoclonal antibody directed against the alpha-

15 Rituximab is a chimeric monoclonal antibody directed at CD20 with signi

16 Basiliximab (Simulect), a high-affinity chimeric, monoclonal antibody directed against the alpha

17 ilability of c7E3 Fab (abciximab; ReoPro), a chimeric monoclonal antibody Fab fragment directed again

18 Phase 1 testing of SGN-30, a chimeric monoclonal antibody for the treatment of CD30(+

19 The murine/human chimeric monoclonal antibody fragment (c7E3 Fab) blocks

20 s directed against this receptor include the chimeric monoclonal antibody fragment abciximab, the pep

21 owing fusion of GDNF to the heavy chain of a chimeric monoclonal antibody (MAb) against the mouse tra

22 , where EPO is fused to the heavy chain of a chimeric monoclonal antibody (MAb) against the mouse tra

23 r the TNFR are fused to the heavy chain of a chimeric monoclonal antibody (MAb) against the mouse tra

24 has been developed wherein EPO is fused to a chimeric monoclonal antibody (MAb) against the mouse tra

25 rase IX (CAIX)-expressing tumor lesions with chimeric monoclonal antibody (mAb) girentuximab, which h

26 IDEC-C2B8 is a chimeric monoclonal antibody (MoAb) directed against the

27 A chimeric monoclonal antibody more effectively mediates h

28 ccessful, compassionate use of the anti-CD20 chimeric monoclonal antibody rituximab in a patient with

29 The chimeric monoclonal antibody rituximab is the standard o

30 Rituximab, a chimeric monoclonal antibody specific for the CD20 B-lym

31 Rituximab, a chimeric monoclonal antibody targeted against the pan-B-

32 Girentuximab is a chimeric monoclonal antibody that binds carbonic anhydra

33 BACKGROUND & AIMS: Basiliximab is a chimeric monoclonal antibody that binds CD25 and thereby

34 ructed immunoglobulin G1 (IgG1) murine-human chimeric monoclonal antibody that binds the soluble subu

35 C225 is a human-to-murine chimeric monoclonal antibody that binds to the receptor

36 Rituximab is a chimeric monoclonal antibody that targets B-cell-specifi

37 Rituximab (Rituxan) is a human-mouse chimeric monoclonal antibody that targets the B-cell CD2

38 Cetuximab is a chimeric monoclonal antibody that targets the epidermal

39 venous infusion of keliximab (IDEC CE9.1), a chimeric monoclonal antibody to CD4.

40 Infliximab, a chimeric monoclonal antibody to TNF-alpha, has been demo

41 ted the efficacy and safety of infliximab, a chimeric monoclonal antibody to TNFalpha, in patients wi

42 Infliximab, a chimeric monoclonal antibody to tumor necrosis factor al

43 pattern of opsonophagocytic activity of the chimeric monoclonal antibodies was similar to that of co

44 Siltuximab is a new anti-IL-6, chimeric monoclonal antibody with potential therapeutic

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。